Analysts Set Expectations for Legend Biotech FY2025 Earnings
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Investment analysts at Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of Legend Biotech in a research note issued to investors on Wednesday, May 14th. Cantor Fitzgerald analyst R. Bienkowski now expects that the company will earn ($0.42) per share for the year, up from their […]
